Trades on 1 secondary market
Catalym
CatalYm GmbH is a clinical-stage biotechnology company based in Planegg-Martinsried near Munich, Germany, developing next-generation cancer immunotherapies. Its lead approach neutralizes GDF-15 (Growth Differentiation Factor 15) to reverse a key immune-resistance mechanism in solid tumors, aiming to
Catalym is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.